期刊文献+

利用实时动态血糖检测系统评价慢重症患者血糖变异性与生存预后的相关性研究 被引量:6

The Correlation Between Serum Glucose Variability and Prognosis in Patients with Chronic Critical Illness by Continuous Glucose Monitoring System
下载PDF
导出
摘要 目的利用实时动态血糖检测系统(continuous glucose monitoring system,CGMS)评价慢重症(chronic critical illness,CCI)患者血糖变异性与生存预后的相关性。方法连续性纳入2014年1月至2016年11月江苏省中医院重症医学科收治的CCI患者共34例,分为存活组(n=14)和死亡组(n=20)。通过CGMS对CCI患者连续72h血糖监测,记录约288个血糖值,作出血糖值图,并计算平均血糖(MBG)、动态平均血糖标准差(SDBG)、平均血糖波动幅度(MAGE)和日间血糖平均绝对差(MODD)等血糖波动评价指数。结果存活组CCI患者SDBG、MAGE和MODD水平明显低于死亡组CCI患者(P<0.05)。ROC曲线分析提示,SDBG(AUC=0.828;95%CI:0.759,0.867;cut-off值为3.92mmol/L;敏感性为83.1%;特异性为86.6%)和MAGE(AUC=0.804;95%CI:0.716,0.839;cut-off值为6.14mmol/L;敏感性为81.5%;特异性为79.8%)诊断价值最高。相关性分析提示,SDBG(r=0.664,P<0.05)和MAGE(r=0.623,P<0.05)水平与CCI患者死亡事件呈正相关。Logistic回归分析提示,SDBG(>3.92mmol/L)(P<0.05)和MAGE(>6.14mmol/L)(P<0.05)为CCI患者死亡事件的独立危险因素。结论血糖波动指数(SDBG和MAGE)有助于预判CCI患者的临床预后。 Objective To evaluate the correlation between serum glucose variability and prognosis in patients with chronic critical illness(CCI)by using continuous glucose monitoring system(CGMS).Methods Thirty-four CCI patients admitted into Jiangsu Province Hospital of TCM from January of 2014 to November of 2016 were enrolled in this study and divided into the survival group(n=14)and the death group(n=20).CGMS was used to monitor the serum glucose of those patients for 72 hours continuously and about 288 readings of serum glucose were recorded to demonstrate the map of serum glucose value and calculate the glucose variability indexes such as MBG,SDBG,MAGE and MODD.Results The levels of SDBG,MAGE and MODD in the survival group were significantly lower than those in the death group(P<0.05).The results of ROC analysis showed that SDBG(AUC=0.828,95%CI:0.759~0.867,Cut-off value:3.92 mmol/L,Sensitivity:83.1%,Specificity:86.6%)and MAGE(AUC=0.804,95%CI:0.716~0.839,Cut-off value:6.14 mmol/L,Sensitivity:81.5%,Specificity;79.8%)have the best diagnostic value.The results of the correlation analysis showed that both SDBG and MAGE were positively correlated with the mortality of CCI patients respectively(r=0.664,P<0.05;r=0.623,P<0.05).The results of Logistic regression analysis showed SDBG(>3.92 mmol/L)(OR=1.88,95%CI:1.11~2.36,P<0.05)and MAGE(>6.14 mmol/L)(OR=1.65,95%CI:1.02~2.15,P<0.05)were the independent risk factors for the mortality of CCI patients.Conclusion The glucose variability indexes including SDBG and MAGE are helpful in predicting the clinical prognosis of CCI patients by using CGMS.
作者 常宁 裴颖皓 Chang Ning;Pei Yinghao(Department of ICU,Jiangsu Province Hospital of TCM,Nanjing 210029,China)
出处 《成都医学院学报》 CAS 2018年第1期54-58,共5页 Journal of Chengdu Medical College
基金 江苏省中医院院级课题(No:Y16044)
关键词 重症 实时动态血糖检测系统 血糖变异性 生存预后 Chronic critical illness Continuous glucose monitoring system Serum glucose variability Prognosis
  • 相关文献

参考文献9

二级参考文献82

  • 1Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression : a common syndrome mad new horizon for surgical intensive care. J Trauma Acute Care Surg, 2012,72 : 1491 - 1501.
  • 2Auron PE, Webb AC, Rosenwasser LJ, et al. Nucleotide sequence of human monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA, 1984,81 : 7907-7911.
  • 3Shirai T, Yamaguchi H, Ito H,et al. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature, 1985,313: 803-806.
  • 4Beutler B, Cerami A. Cachectin : more than a tumor necrosis factor. N Engl J Med, 1987,316 : 379-385.
  • 5Okusawa S, Gelfand JA, Ikejima T, et al. Interleukin 1 induces a shock-like state in rabbits : synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest, 1988,81 : 1162-1172.
  • 6Bone RC, Grodzin C J, Balk RA. Sepsis : a new hypothesis for pathogenesis of the disease process. Chest, 1997,112 : 235-243.
  • 7Kawai T, Akira S. Signaling to NF-kappa B by Toll-like receptors. Trends Mol Med, 2007,13 : 460-469.
  • 8Wiersinga WJ. Current insights in sepsis:from pathogenesis to new treatment targets. Curr Opin Crit C~re, 2011,17:480-486.
  • 9Mitka M. Drug for severe sepsis is withdrawn from market, fails to reduce mortality. JAMA, 2011,306 : 2439-2440.
  • 10Qiu P, Cui X, Barochia A, et al. The evolving experience with therapeutic TNF inhibition in sepsis:considering the potential influence of risk of death. Expert Opin Investig Drugs, 2010,20 : 1555-1564.

共引文献88

同被引文献40

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部